317 related articles for article (PubMed ID: 30510493)
21. Ratio of lymph node to primary tumor SUVmax multiplied by maximal tumor diameter on positron emission tomography/integrated computed tomography may be a predictor of mediastinal lymph node malignancy in lung cancer.
Liu Y; Tang Y; Xue Z; Yang P; Ma K; Ma G; Chu X
Medicine (Baltimore); 2016 Nov; 95(46):e5457. PubMed ID: 27861398
[TBL] [Abstract][Full Text] [Related]
22. FDG uptake in cervical lymph nodes in children without head and neck cancer.
Vali R; Bakkari A; Marie E; Kousha M; Charron M; Shammas A
Pediatr Radiol; 2017 Jun; 47(7):860-867. PubMed ID: 28357549
[TBL] [Abstract][Full Text] [Related]
23. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation.
Kumar A; Dutta R; Kannan U; Kumar R; Khilnani GC; Gupta SD
Ann Thorac Med; 2011 Jan; 6(1):11-6. PubMed ID: 21264165
[TBL] [Abstract][Full Text] [Related]
25. Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease?
Ozmen O; Tatci E; Uslu Biner I; Findik G; Yilmaz U; Erturk H; Demirag F
Clin Respir J; 2019 Jan; 13(1):58-65. PubMed ID: 30556309
[TBL] [Abstract][Full Text] [Related]
26. Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.
Kim DW; Kim CG
Jpn J Radiol; 2011 Dec; 29(10):682-7. PubMed ID: 22009418
[TBL] [Abstract][Full Text] [Related]
27. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
Honguero Martínez AF; García Jiménez MD; García Vicente A; López-Torres Hidalgo J; Colon MJ; van Gómez López O; Soriano Castrejón ÁM; León Atance P
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):159-64. PubMed ID: 26514322
[TBL] [Abstract][Full Text] [Related]
28. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
[TBL] [Abstract][Full Text] [Related]
29. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT.
Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX
Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404
[TBL] [Abstract][Full Text] [Related]
30. Utility of SUV
Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E
Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180
[TBL] [Abstract][Full Text] [Related]
31. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
[TBL] [Abstract][Full Text] [Related]
32. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
33. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma.
Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiën HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC
Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Wang Y; Ma S; Dong M; Yao Y; Liu K; Zhou J
BMC Pulm Med; 2015 Mar; 15():20. PubMed ID: 25880540
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Tech Coloproctol; 2018 May; 22(5):347-354. PubMed ID: 29623475
[TBL] [Abstract][Full Text] [Related]
36. Cervical lymph node hyperplasia on [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography scan after treatment of children and adolescents with malignant lymphoma.
Hu YY; Zhang X; Long W; Lin XP; Zhang YR; Li YH; Xiao ZZ; Zheng RL; Liang PY; Fan W
Eur J Radiol; 2015 Jul; 84(7):1378-82. PubMed ID: 25882963
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT.
Park B; Kim HK; Choi YS; Kim J; Zo JI; Choi JY; Shim YM
Korean J Radiol; 2015; 16(4):929-35. PubMed ID: 26175595
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
Gupta NC; Graeber GM; Bishop HA
Chest; 2000 Mar; 117(3):773-8. PubMed ID: 10713005
[TBL] [Abstract][Full Text] [Related]
40. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
